These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 1847186)
21. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. Witkin JM; Steele TD; Sharpe LG J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180 [TBL] [Abstract][Full Text] [Related]
22. Kinetic characterization of the phencyclidine-N-methyl-D-aspartate receptor interaction: evidence for a steric blockade of the channel. Kloog Y; Haring R; Sokolovsky M Biochemistry; 1988 Feb; 27(3):843-8. PubMed ID: 2835078 [TBL] [Abstract][Full Text] [Related]
23. RTI-4793-14, a new ligand with high affinity and selectivity for the (+)-MK801-insensitive [3H]1-]1-(2-thienyl)cyclohexyl]piperidine binding site (PCP site 2) of guinea pig brain. Goodman CB; Thomas DN; Pert A; Emilien B; Cadet JL; Carroll FI; Blough BE; Mascarella SW; Rogawski MA; Subramaniam S Synapse; 1994 Jan; 16(1):59-65. PubMed ID: 8134901 [TBL] [Abstract][Full Text] [Related]
24. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Bristow LJ; Hutson PH; Thorn L; Tricklebank MD Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625 [TBL] [Abstract][Full Text] [Related]
25. Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Lockhart BP; Soulard P; Benicourt C; Privat A; Junien JL Brain Res; 1995 Mar; 675(1-2):110-20. PubMed ID: 7796119 [TBL] [Abstract][Full Text] [Related]
26. Distinctive structural requirement for the binding of uncompetitive blockers (phencyclidine-like drugs) to the NMDA receptor. Nadler V; Kloog Y; Sokolovsky M Eur J Pharmacol; 1990 Mar; 188(2-3):97-104. PubMed ID: 2156715 [TBL] [Abstract][Full Text] [Related]
27. Photoaffinity labeling and binding studies reveal the existence of two types of phencyclidine receptors in the NCB-20 cell line. Haring R; Zukin RS; Zukin SR Neurosci Lett; 1990 Apr; 112(1):92-8. PubMed ID: 2166931 [TBL] [Abstract][Full Text] [Related]
28. Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists: evidence for possible allosteric coupling of NMDA and PCP receptors. Wood PL; Steel D; McPherson SE; Cheney DL; Lehmann J Can J Physiol Pharmacol; 1987 Sep; 65(9):1923-7. PubMed ID: 2825947 [TBL] [Abstract][Full Text] [Related]
29. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo. Snell LD; Mueller ZL; Gannon RL; Silverman PB; Johnson KM J Pharmacol Exp Ther; 1984 Nov; 231(2):261-9. PubMed ID: 6092611 [TBL] [Abstract][Full Text] [Related]
30. Development of dopamine and N-methyl-D-aspartate systems in rat brain: the effect of prenatal phencyclidine exposure. Ali SF; Holson RR; Newport GD; Slikker W; Bowyer JF Brain Res Dev Brain Res; 1993 May; 73(1):25-33. PubMed ID: 7685665 [TBL] [Abstract][Full Text] [Related]
31. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties. Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669 [TBL] [Abstract][Full Text] [Related]
32. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex. Carter CJ; Lloyd KG; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016 [TBL] [Abstract][Full Text] [Related]
33. The antidepressant metapramine is a low-affinity antagonist at N-methyl-D-aspartic acid receptors. Boireau A; Bordier F; Durand G; Doble A Neuropharmacology; 1996; 35(12):1703-7. PubMed ID: 9076749 [TBL] [Abstract][Full Text] [Related]
34. Quantitative autoradiographic localization of [3H]3-OH-PCP (1-(1(3-hydroxyphenyl)cyclohexyl)piperidine) binding sites in rat brain. Suzuki T; Yamamoto T; Hori T; Abe S; Moroji T; Shiraishi H; Ito T; Ho IK Brain Res Bull; 1995; 37(4):431-5. PubMed ID: 7620917 [TBL] [Abstract][Full Text] [Related]
35. Phencyclidine and sigma receptors in rat spinal cord: binding characterization and quantitative autoradiography. Aanonsen LM; Seybold VS Synapse; 1989; 4(1):1-10. PubMed ID: 2549651 [TBL] [Abstract][Full Text] [Related]
36. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors. Löscher W; Hönack D J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288 [TBL] [Abstract][Full Text] [Related]
37. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253 [TBL] [Abstract][Full Text] [Related]
38. [3H]1-[2-(2-thienyl)cyclohexyl]piperidine labels two high-affinity binding sites in human cortex: further evidence for phencyclidine binding sites associated with the biogenic amine reuptake complex. Akunne HC; Reid AA; Thurkauf A; Jacobson AE; de Costa BR; Rice KC; Heyes MP; Rothman RB Synapse; 1991 Aug; 8(4):289-300. PubMed ID: 1833849 [TBL] [Abstract][Full Text] [Related]
39. N-methyl-D-aspartate/phencyclidine receptor complex of rat forebrain: purification and biochemical characterization. Ikin AF; Kloog Y; Sokolovsky M Biochemistry; 1990 Mar; 29(9):2290-5. PubMed ID: 2159797 [TBL] [Abstract][Full Text] [Related]
40. Rat brain N-methyl-D-aspartate receptors require multiple molecules of agonist for activation. Javitt DC; Frusciante MJ; Zukin SR Mol Pharmacol; 1990 May; 37(5):603-7. PubMed ID: 2160056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]